Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-08-004833
Filing Date
2008-04-29
Accepted
2008-04-29 15:45:51
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A y56666e10vkza.htm 10-K/A 171836
2 EX-31.1:CERTIFICATION y56666exv31w1.htm EX-31.1 8441
3 EX-31.2:CERTIFICATION y56666exv31w2.htm EX-31.2 8461
4 EX-32.1:CERTIFICATION y56666exv32w1.htm EX-32.1 3296
5 EX-32.2:CERTIFICATION y56666exv32w2.htm EX-32.2 3305
6 GRAPHIC y56666y5666601.gif GRAPHIC 10082
  Complete submission text file 0000950123-08-004833.txt   210818
Mailing Address 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022 212-716-1810
Innovive Pharmaceuticals, Inc. (Filer) CIK: 0001337223 (see all company filings)

EIN.: 743123261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-51534 | Film No.: 08785258
SIC: 2836 Biological Products, (No Diagnostic Substances)